Disposable nose pack for nosebleeds

Information

  • Patent Grant
  • 8604267
  • Patent Number
    8,604,267
  • Date Filed
    Monday, June 9, 2008
    16 years ago
  • Date Issued
    Tuesday, December 10, 2013
    10 years ago
Abstract
A cylindrical absorbent cotton nasal pack has a rounded tip for a patient's self application in controlling epistaxis. The pack comprises compressed absorbent cotton or cellulosic fiber in the shape of a bullet or capsule to prevent sticking to nasal wall and absorption of blood. One end has a rounded tip and the other end has a flat bottom section (optional dual rounded ends). The flat bottom section has a plastic coating or plastic sleeve made of polyurethane to help grip the nose pack, conceal the site of blood, prevent blood leakage, and prevent contact of blood when disposing of the nose pack. The nose pack is simply inserted with the cotton rounded side up into the bleeding nasal cavity while applying a gentle pushing force until pack is snug at top of nasal cavity. The constant pressure applied from the pack to the nostril wall assists in the coagulation process, which helps stop the nosebleed. The nose pack is sized to be placed within the nasal cavity upon occurrence of a nosebleed. When the nosebleed is ended, the nose pack may be removed by applying a gentle pulling force to the bottom of the nose pack to remove from nasal cavity. When removing the pack, blood clots that collected during the coagulation process will also naturally be released.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates generally to disposable epistaxis treatments, which can be applied with ease by patient without medical assistance.


2. Description of Prior Art


Epistaxis, also known as “nosebleed,” is a common problem. There are many causes for nosebleeds which can be propagated by excessive drying of nasal mucous membrane, trauma (physical damage), hypertension (high blood pressure), and sinusitis, among other disorders. Nosebleeds frequently occur at unpredictable times and can be dangerous if not controlled causing unconsciousness or even death. Because of the frequency, unpredictability and danger of nosebleeds, it is critical that treatment for nosebleeds be readily available, especially for those people with chronic nosebleeds. According to OSHA, there are regulations regarding contact of blood and many people are fearful that the blood may be contaminated with blood borne pathogens such as AIDS or HIV. Players in sporting events cannot continue playing if blood is seen by the referee, unless the nose bleed is “contained”. This nose pack has a compacted design to help conceal the problem of a nosebleed thereby preventing embarrassment of messy blood. For these reasons, many attempts have been made to meet the need for a simple and ready to use treatment with the ability to conceal a nosebleed for epistaxis. All attempts in the prior art have failed to satisfactorily meet these needs. A satisfactory treatment would be non conspicuous, effective, easily disposable, convenient, cost effective and easy to apply, while not intimidating patients.


Field of Search
References Cited











US Patent Documents



















592659
October 1897
Miller et al.



1042624
October 1912
Wagoner



1133770
March 1915
Wedler



1235095
July 1917
Beck



1887526
November 1932
Spielberg et al.



2691985
October 1954
Newsom



3049125
August 1962
Kriwkowitsch



3570494
March 1971
Gottschalk



3618607
October 1971
Ells, et al



3850176
November 1974
Gottschalk



4030504
June 1977
Doyle



4568326
February 1986
Rangaswamy



4646739
March 1987
Doyle



4705514
November 1987
Barnard



4895559
January 1990
Shippert



5011474
April 1991
Brennan



5327897
July 1994
Andresen



5383891
January 1995
Walker



5568808
October 1996
Rimkus



5584822
December 1996
Lively



5713855
February 1998
Shippert



5827224
October 1998
Shippert



5890491
April 1999
Rimkus



6123697
September 2000
Shippert



6216694
April 2001
Chen



5531703
July 1996
Skwarek



2003/0167048
September 2003
Policappelli



2006/0036206
February 2006
Yokoyama et al.










SUMMARY OF THE INVENTION

A nasal pack according to the present invention is cylindrical in shape and is suitable for a patient's self application in controlling epistaxis. The pack has a widget comprised of compressed cotton or cellulosic fiber. The term “widget” is used in this application to refer to a pack dimensioned and configured to fit within the human nasal cavity. The widget is extended just past the opening of the nostril providing a place on which to grip the pack also allowing containment and prevent contact of blood when disposing of pack. The widget is placed within the nasal cavity upon occurrence of a nosebleed thereby absorbing blood and at the same time applying constant pressure to the nasal wall to assist in the coagulation process stopping the nosebleed. When the nosebleed is ended, the pack may be removed by applying a gentle pulling force to the bottom of the nose pack. Blood clots will naturally expel at time of removal clearing the nasal sinuses.


Accordingly, it is a principal object of the invention to provide simple, ready to use, effective treatment for epistaxis which can be applied and removed without assistance designed to conceal the problem of a nosebleed.


An additional object of the invention is to provide a treatment for epistaxis in which constant, continued pressure is applied to the nostril assisting in stopping the nosebleed.


A further object of the invention is to provide convenience of a nosebleed treatment that is easy to transport and conceal.


It is an object of the invention to provide improved elements and arrangements thereof in an apparatus for the purposes described which is reliable, disposable, inexpensive and fully effective in accomplishing its intended purposes.


These and other obvious objects of the present invention will become apparent upon further review of the following specification and drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of the completed nose pack positioned to be inserted into the inside of a nostril.



FIG. 2A is a side view of an elongate body comprising compressed absorbent cotton formed into a cylindrical shape with a rounded tip at one end according to a first embodiment.



FIG. 2B is a side view of an elongate body comprising compressed absorbent cotton formed into a cylindrical shape with rounded tips at both ends according to a second embodiment.



FIG. 3 is a side view of a clear or colored plastic coating or sleeve for covering the lower portion and lower end of the elongate body shown in FIG. 2A.



FIG. 4 is a side view of the nose pack completed and ready to package, with the upper portion and rounded tip covered by a lubricant or medication.





DETAILED DESCRIPTION OF INVENTION

A nose pack 10 for controlling epistaxis according to the present invention will be explained in detail with reference to FIGS. 1 to 4 of the accompanying drawings.


The nose pack 10 includes an elongate body 1 comprising compressed absorbent cotton formed into a cylindrical shape with a rounded upper end 11. The cylindrical shape has an upper portion 12 adjacent to the rounded upper end 11, and a lower portion 13. The rounded upper end 11 and the upper portion 12 of the elongate body 1 are dimensioned and configured to fit into a nostril 2.


The elongate body 1 has a lower end 14 opposite to the rounded upper end 11. The lower portion 13 and the lower end 14 of the elongate body 1 are covered by a plastic coating or plastic sleeve 3. The plastic coating or plastic sleeve 3 is arranged to contain blood within the absorbent cotton of the elongate body 1 and to provide a place to grip the pack 10 without contacting blood absorbed by the absorbent cotton.


An alternative embodiment of an elongate body 5 for the nose pack 10 of the present invention is illustrated in FIG. 2B. The elongate body 5 of this embodiment has a rounded upper end 11′ and a rounded lower end 14′.


The plastic coating or plastic sleeve 3 can be colored to conceal blood absorbed into the lower portion 13 of the elongate body 1 during use. The plastic coating or plastic sleeve 3 can be permanently attached and sealed to the lower portion 13 of the elongate body 1.


As illustrated in FIG. 4, the upper portion 12 and rounded upper end 11 can be prelubricated with a lubricant 4 for lubricating a nasal wall during use, or premedicated with a medication 4 for applying medicine to a nasal wall during use. The nose pack 10 can be used as an applicator to apply lubricants to relieve dry nasal walls to prevent recurring nosebleeds. The nose pack 10 can also be used as a new and effective method for delivering medications into the blood system.

Claims
  • 1. A nose pack for controlling epistaxis, consisting of: an elongate body comprising compressed absorbent cotton, anda plastic coating or plastic sleeve covering a portion of said elongate body;said compressed absorbent cotton being formed into a cylindrical shape with a rounded upper end, said cylindrical shape having an upper portion adjacent to said rounded upper end and a lower portion, said rounded upper end and said upper portion of said elongate body being dimensioned and configured to provide a means for fitting into a human nostril and applying a constant pressure to a nasal wall of the nostril;said elongate body comprising a lower end opposite to said rounded upper end, said lower portion and said lower end of said elongate body being covered and sealed by said plastic coating or plastic sleeve to contain blood within said absorbent cotton and to provide a place to grip the pack without contacting blood absorbed by said absorbent cotton;wherein said plastic coating or plastic sleeve closely conforms to the lower portion and lower end of the elongate body so as not to protrude substantially beyond the cylindrical shape of said elongate body.
  • 2. The nose pack according to claim 1, wherein said upper portion is prelubricated for lubricating a nasal wall during use.
  • 3. The nose pack according to claim 1, wherein said upper portion of the elongate body is premedicated for applying medicine to a nasal wall during use.
  • 4. The nose pack according to claim 1, wherein said lower end of said elongate body is rounded.
  • 5. The nose pack according to claim 1, wherein said plastic coating or plastic sleeve is colored to conceal blood absorbed into the lower portion of said elongate body during use.
  • 6. The nose pack according to claim 1, wherein said plastic coating or plastic sleeve is permanently attached and sealed to the lower portion of said elongate body.
  • 7. The nose pack according to claim 1, wherein said lower end of the elongate body extends just below an opening of the nostril during use.
US Referenced Citations (41)
Number Name Date Kind
592659 Miller et al. Oct 1897 A
1042624 Wagoner Oct 1912 A
1133770 Wedler Mar 1915 A
1235095 Beck Jul 1917 A
1887526 Spielberg et al. Nov 1932 A
2691985 Newsom Oct 1954 A
3038214 Griswold et al. Jun 1962 A
3049125 Kriwkowitsch Aug 1962 A
3570494 Gottschalk Mar 1971 A
3618607 Ells et al. Nov 1971 A
3850176 Gottschalk Nov 1974 A
4030504 Doyle Jun 1977 A
4568326 Rangaswamy Feb 1986 A
4646739 Doyle Mar 1987 A
4705514 Barnard Nov 1987 A
4820266 Berry Apr 1989 A
4895559 Shippert Jan 1990 A
4952204 Korteweg Aug 1990 A
5011474 Brennan Apr 1991 A
5327897 Andresen Jul 1994 A
5383891 Walker Jan 1995 A
5531703 Skwarek et al. Jul 1996 A
5568808 Rimdus Oct 1996 A
5584822 Lively et al. Dec 1996 A
5713855 Shippert Feb 1998 A
5827224 Shippert Oct 1998 A
5890491 Rimkus Apr 1999 A
5891123 Balzar Apr 1999 A
6123697 Shippert Sep 2000 A
6216694 Chen Apr 2001 B1
6517509 Shippert Feb 2003 B1
6559352 Zadini et al. May 2003 B2
6768040 Sessions et al. Jul 2004 B1
7294138 Shippert Nov 2007 B2
7789845 Meliti Sep 2010 B1
20010001788 Satoh et al. May 2001 A1
20030167048 Policappelli Sep 2003 A1
20050054967 Ashe et al. Mar 2005 A1
20050288620 Shippert Dec 2005 A1
20060036206 Yokoyama et al. Feb 2006 A1
20060137069 Yang et al. Jun 2006 A1
Related Publications (1)
Number Date Country
20090306575 A1 Dec 2009 US